Supplementary Table S2 from Whole-Exome Sequencing Analysis of the Progression from Non–Low-Grade Ductal Carcinoma <i>In Situ</i> to Invasive Ductal Carcinoma

Fresia Pareja,D. N. Brown,Ju Youn Lee,Arnaud Da Cruz Paula,Pier Selenica,Rui Bi,Felipe C. Geyer,Andrea Gazzo,Edaise M. da Silva,Mahsa Vahdatinia,Anthe A. Stylianou,Lorenzo Ferrando,Hannah Y. Wen,James Hicks,Britta Weigelt,Jorge S. Reis‐Filho
DOI: https://doi.org/10.1158/1078-0432.22475403.v1
2023-01-01
Abstract:Supplementary Table S2 shows the non-synonymous somatic mutations identified in synchronous DCIS and IDC-NSTs subjected to whole-exome sequencing or MSK-IMPACT targeted massively parallel sequencing and/or targeted amplicon sequencing.
What problem does this paper attempt to address?